Rinvoq ER 45 MG tablet UU 28S
Ended Awarded Last action
- Contract number
- SPE2DR26FJF6B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $51,079
Award facts
- Contract value 100% obligated
- $51,078.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of RINVOQ ER 45 mg tablets (28-count units) under a firm fixed-price contract valued at $51,078.91. This is a non-set-aside competitive award with a completion date of December 31, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order serves as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables comprehensive global pharmaceutical support for military healthcare programs.
AmerisourceBergen Drug Corp, one of the nation's leading pharmaceutical distributors, supplies critical medications and medical commodities across multiple therapeutic domains to support federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company's extensive federal contract portfolio demonstrates its capability to fulfill competitive procurement requirements for brand-name and generic pharmaceuticals, vaccines, medical devices, and specialized healthcare supplies. This particular delivery order for RINVOQ ER, a JAK inhibitor used to treat rheumatoid arthritis, reflects the company's ongoing role as a key supplier for military and veteran healthcare needs through the DLA's pharmaceutical prime vendor global program.
Quick answers
Who was awarded contract SPE2DR26FJF6B?
SPE2DR26FJF6B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 30, 2025.
How much is contract SPE2DR26FJF6B worth?
The government has obligated $51,079 on SPE2DR26FJF6B.
Is contract SPE2DR26FJF6B an order under another contract?
Yes. SPE2DR26FJF6B is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJF6B competed?
The extent of competition for SPE2DR26FJF6B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award